English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17938/22957 (78%)
Visitors : 7397023      Online Users : 272
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/10714


    Title: Oat prevents obesity and abdominal fat distribution, and improves liver function in humans.
    Authors: Chang, HC
    Huang, CN
    Yeh, DM
    Wang, SJ
    Peng, CH
    Wang, CJ
    Contributors: 中山醫學大學
    Keywords: Oat;Obesity;Abdominal body fat;Fatty liver
    Date: 2013
    Issue Date: 2015-05-04T09:53:21Z (UTC)
    ISSN: 0921-9668
    Abstract: Obesity is associated with a great diversity of diseases including non-alcoholic fatty liver disease. Our recent report suggested that oat, rich in beta-glucan, had a metabolic-regulating and liver-protecting effect in an animal model. In this study, we performed a clinical trial to further confirm the effect of oat. Subjects with BMI ≥27 and aged 18-65, were randomly divided into a control (n=18) and an oat-treated (n=16) group, taking a placebo or beta glucan-containing oat cereal, respectively, for 12 weeks. Our data showed that consumption of oat reduced body weight, BMI, body fat and the waist-to-hip ratio. Profiles of hepatic function, including AST, but especially ALT, were useful resources to help in the evaluation of the liver, since both showed decrements in patients with oat consumption. Nevertheless, anatomic changes were still not observed by ultrasonic image analysis. Ingestion of oat was well tolerated and there was no adverse effect during the trial. In conclusion, consumption of oat reduced obesity, abdominal fat, and improved lipid profiles and liver functions. Taken as a daily supplement, oat could act as an adjuvant therapy for metabolic disorders.
    PMID: 23371785 [PubMed - indexed for MEDLINE]
    URI: https://ir.csmu.edu.tw:8080/ir/handle/310902500/10714
    http://dx.doi.org/10.1007/s11130-013-0336-2
    Relation: Plant Foods Hum Nutr. 2013 Mar;68(1):18-23.
    Appears in Collections:[生化微生物免疫研究所] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html期刊論文0KbHTML549View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback